Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REVEAL: Epoetin alfa in acute ST-elevation myocardial infarction
NCT00378352Phase 2Completed
- Sponsor
- National Institute on Aging
- Start
- Sep 2005
- Primary completion
- Jul 2009
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in myocardial infarction (MI), sponsored by National Institute on Aging. Started Sep 2005; status: completed.
02
Drugs
epoetin alfa
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT00378352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00378352.